Autonomous Therapeutics, Inc.
PrivateLast Round
Grant
Dec 20, 2024
Total Funding Raised
$55.31M
Company Overview
Autonomous Therapeutics, Inc. is a biotechnology company that develops precision nucleic acid-based therapeutics for the treatment of infectious diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autonomous Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Autonomous Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2024 | ||||
| Grant | Aug 24, 2023 | ||||
| Grant | May 7, 2021 | ||||
| Grant | Feb 21, 2020 | ||||
| Grant | Nov 8, 2019 | ||||
Grant | Dec 28, 2017 |
Autonomous Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Department of the Interior | Grant |
| Naval Air Warfare Center | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Defense Advanced Research Projects Agency | Grant |
| National Institutes of Health (NIH) | Grant |
| Johnson & Johnson Innovation - JLABS | Grant |
| Third Kind Venture Capital | Early Funding |
Autonomous Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Autonomous Therapeutics, Inc.'s valuation, stock price, and market status.